e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Epidemiological and clinical aspects of tuberculosis control
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment results of multidrug resistant tuberculosis and the factors affecting treatment results
D. Duman, T. Karagoz, P. Pazarli, O. Yazicioglu Mocin (Istanbul, Sakarya, Turkey)
Source:
Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control
Session:
Epidemiological and clinical aspects of tuberculosis control
Session type:
E-Communication Session
Number:
3038
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Duman, T. Karagoz, P. Pazarli, O. Yazicioglu Mocin (Istanbul, Sakarya, Turkey). Treatment results of multidrug resistant tuberculosis and the factors affecting treatment results. Eur Respir J 2008; 32: Suppl. 52, 3038
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Evaluation of characteristics and treatment results of patients treated as multidrug resistant tuberculosis
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
The adverse effects of multidrug resistant tuberculosis treatment and relationship with treatment results
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
The clinical features and treatment results of cases with multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
Outcome of multidrug resistant tuberculosis (MDR-TB) treatment with possible influencing factors
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Treatment outcome of multidrug resistant tuberculosis with second line drugs
Source: Eur Respir J 2001; 18: Suppl. 33, 314s
Year: 2001
Treatment outcome of multi-drug resistant tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
Long-term results of drug resistant tuberculosis treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 378s
Year: 2006
Treatment results of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 199s
Year: 2005
Risk factors for rifampicine resistant tuberculosis cases and treatment results with standard regimens
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002
Treatment results and follow up of patients with chronic multidrug resistant tuberculosis
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004
Second and third line anti-tuberculosis drug's side effects during the treatment of patients with multidrug resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 555s
Year: 2003
Treatment possibilities of multi-drug resistant (MDR) tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 525s
Year: 2003
Strategies against multidrug-resistant tuberculosis
Source: Eur Respir J 2002; 20: 66S-77S
Year: 2002
Long-term results of multidrug-resistant tuberculosis treatment.
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018
Treatment of resistant tuberculosis in patients having isolates resistant to multiple antituberculosis drugs
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
Unit of multidrug resistant tuberculosis - effect of treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 614s
Year: 2002
Treatment results for MDR TB patients after surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept